Mirati Therapeutics (MRTX) Phase 3 SAPPHIRE Study Evaluating Sitravatinib in Combination with OPDIVO Does Not Meet Primary Endpoint
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.